Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 98802802 | 9880280 | 2 | F | 201206 | 20140128 | 20140207 | 20160726 | EXP | DE-ROCHE-1341465 | ROCHE | 51.16 | YR | M | Y | 66.00000 | KG | 20160726 | MD | DE | DE |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 98802802 | 9880280 | 1 | PS | CAPECITABINE. | CAPECITABINE | 1 | Unknown | U | 20896 | 1500 | MG | BID | |||||||
| 98802802 | 9880280 | 2 | SS | CAPECITABINE. | CAPECITABINE | 1 | Unknown | U | 20896 | 1500 | MG | BID | |||||||
| 98802802 | 9880280 | 3 | SS | Bevacizumab | BEVACIZUMAB | 1 | Unknown | 125085 | SOLUTION FOR INFUSION | ||||||||||
| 98802802 | 9880280 | 4 | C | MITOMYCIN. | MITOMYCIN | 1 | Intravenous (not otherwise specified) | 15MG | 0 | 7 | MG/M**2 | ||||||||
| 98802802 | 9880280 | 5 | C | FLUOROURACIL. | FLUOROURACIL | 1 | Unknown | 0 | |||||||||||
| 98802802 | 9880280 | 6 | C | FLUOROURACIL. | FLUOROURACIL | 1 | Unknown | 0 | |||||||||||
| 98802802 | 9880280 | 7 | C | Folinic acid | LEUCOVORIN | 1 | Unknown | 0 | |||||||||||
| 98802802 | 9880280 | 8 | C | Folinic acid | LEUCOVORIN | 1 | Unknown | 0 | |||||||||||
| 98802802 | 9880280 | 9 | C | METOCLOPRAMIDE. | METOCLOPRAMIDE | 1 | Unknown | 0 | |||||||||||
| 98802802 | 9880280 | 10 | C | VERGENTAN | 2 | Unknown | 2 AMPOULES | 0 | |||||||||||
| 98802802 | 9880280 | 11 | C | DEXAMETHASON | DEXAMETHASONE | 1 | Unknown | 0 | 8 | MG | |||||||||
| 98802802 | 9880280 | 12 | C | IRINOTECAN | IRINOTECAN | 1 | Unknown | 0 | |||||||||||
| 98802802 | 9880280 | 13 | C | OXALIPLATIN. | OXALIPLATIN | 1 | Unknown | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 98802802 | 9880280 | 1 | Colorectal cancer metastatic |
| 98802802 | 9880280 | 3 | Colorectal cancer metastatic |
| 98802802 | 9880280 | 4 | Colorectal cancer metastatic |
| 98802802 | 9880280 | 5 | Colorectal cancer metastatic |
| 98802802 | 9880280 | 7 | Colorectal cancer metastatic |
| 98802802 | 9880280 | 12 | Colorectal cancer metastatic |
| 98802802 | 9880280 | 13 | Colorectal cancer metastatic |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 98802802 | 9880280 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 98802802 | 9880280 | Diarrhoea | |
| 98802802 | 9880280 | Malignant neoplasm progression | |
| 98802802 | 9880280 | Prerenal failure | |
| 98802802 | 9880280 | Sepsis | |
| 98802802 | 9880280 | Venous thrombosis limb |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 98802802 | 9880280 | 1 | 20131219 | 20140101 | 0 | |
| 98802802 | 9880280 | 2 | 20140108 | 20140122 | 0 | |
| 98802802 | 9880280 | 3 | 201202 | 201206 | 0 | |
| 98802802 | 9880280 | 4 | 20131218 | 0 | ||
| 98802802 | 9880280 | 5 | 201210 | 201304 | 0 | |
| 98802802 | 9880280 | 6 | 201304 | 201309 | 0 | |
| 98802802 | 9880280 | 7 | 201210 | 201304 | 0 | |
| 98802802 | 9880280 | 8 | 201304 | 201309 | 0 | |
| 98802802 | 9880280 | 12 | 201201 | 201210 | 0 | |
| 98802802 | 9880280 | 13 | 201304 | 201309 | 0 |